Rankings
▼
Calendar
GUTS
Fractyl Health, Inc. Common Stock
$34M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$8M
Net Income
-$8M
EPS (Diluted)
$-0.17
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$400,000
Balance Sheet
Total Assets
$35M
Total Liabilities
$20M
Stockholders' Equity
$15M
Cash & Equivalents
$29M
← FY 2020
All Quarters
Q1 2021 →
GUTS Q4 2020 Earnings — Fractyl Health, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
